ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise against advanced uterine cancer
Disease control CompletedThis study tested a combination of two drugs, lenvatinib and pembrolizumab, against standard chemotherapy for advanced endometrial cancer that had worsened after initial treatment. Over 800 participants were randomly assigned to receive either the new combination or a standard ch…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 26, 2026 08:45 UTC
-
New drug combo shows promise in fighting advanced uterine cancer
Disease control CompletedThis study compared a combination of two drugs (pembrolizumab and lenvatinib) to standard chemotherapy in 842 women with advanced or recurrent endometrial cancer. The goal was to see if the combo could better delay cancer growth and improve survival. Participants received either …
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New drug combo shows promise against tough uterine cancer
Disease control CompletedThis study tested whether a combination of two drugs (pembrolizumab and lenvatinib) works better than standard chemotherapy for women with advanced or recurrent endometrial cancer. About 130 women with stage III, IV, or recurrent disease took part. The goal was to see if the comb…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New dye technique may improve lymph node detection in uterine cancer
Knowledge-focused CompletedThis study tested a new method for injecting a green dye to help surgeons find the first lymph nodes that cancer might spread to in early-stage endometrial cancer. 80 women took part, and the new method aimed to show the dye moving in real time. The goal was to see if this approa…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: NA • Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:47 UTC
-
New EHR tool aims to boost heart health talks for cancer survivors
Knowledge-focused CompletedThis study tested a computer tool that helps doctors and cancer survivors discuss heart health during follow-up visits. About 645 survivors of breast, prostate, colorectal, endometrial, and lymphoma cancers took part. The goal was to see if the tool leads to more conversations ab…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC